Nicola Burgess-Brown

Nicola Burgess-Brown

SGC UCL

Burgess-Brown

Nicola Burgess-Brown

nburgessbrown@thesgc.org

Biography

Nicola Burgess-Brown was born in Northern Ireland. After graduating with a degree in biochemistry from the University of Ulster, she moved to SmithKline Beecham where she worked for 1 year before pursuing a PhD in Molecular Microbiology at Nottingham, also sponsored by SB. She then moved to Oxford GlycoSciences, in a team that aimed to identify and validate novel oncology targets for generating therapeutic antibodies. Nicola returned to academia to the University of Oxford to lead a team in Biotechnology within the Structural Genomics Consortium. Over the course of 17 years, working in a highly collaborative environment, her team developed cutting edge technologies and high-throughput (HTP) platforms to express a plethora of very challenging human proteins for structural and functional analyses. From September 2021, she led the Enzymology and Protein Engineering Team at Exact Sciences Innovation in Oxford, producing proteins for cancer diagnostic research. Since January 2024, she rejoined the SGC, working as a consultant (Chief Operating Officer, Protein Sciences) coordinating protein production across the 6 SGC sites and, from April 2025, became a Professorial Research Fellow in Protein Sciences at UCL. 

Research Areas

Nicola's research interests include developing novel technologies to express and purify proteins for many applications including drug discovery, cancer diagnostics and vaccine development. She is interested in finding new methods for tackling highly challenging proteins, and at Oxford, developed methodologies for expressing and purifying human integral membrane proteins. She is also keen to work on targets involved in antimicrobial resistance, having studied quorum sensing during her PhD. Throughout her career, she has enjoyed collaborative research which has enabled productive interactions with colleagues in academia and industry partners.

2024

Structural basis for inhibition of the lysosomal two-pore channel TPC2 by a small molecule antagonist.

Chi G, Jaślan D, Kudrina V, Böck J, Li H, Pike ACW, Rautenberg S, Krogsaeter E, Bohstedt T, Wang D, McKinley G, Fernandez-Cid A, Mukhopadhyay SMM, Burgess-Brown NA, Keller M, Bracher F, Grimm C, Dürr KL

Structure. 2024-5-23 . .doi: 10.1016/j.str.2024.05.005

PMID: 38815576

2022

Cryo-EM structure of the human Kv3.1 channel reveals gating control by the cytoplasmic T1 domain.

Chi G, Liang Q, Sridhar A, Cowgill JB, Sader K, Radjainia M, Qian P, Castro-Hartmann P, Venkaya S, Singh NK, McKinley G, Fernandez-Cid A, Mukhopadhyay SMM, Burgess-Brown NA, Delemotte L, Covarrubias M, Dürr KL

Nat Commun. 2022-7-15 . 13(1):4087 .doi: 10.1038/s41467-022-29594-w

PMID: 35840580

2021

The structural basis of fatty acid elongation by the ELOVL elongases.

Nie L, Pascoa TC, Pike ACW, Bushell SR, Quigley A, Ruda GF, Chu A, Cole V, Speedman D, Moreira T, Shrestha L, Mukhopadhyay SMM, Burgess-Brown NA, Love JD, Brennan PE, Carpenter EP

Nat Struct Mol Biol. 2021-6-13 . 28(6):512-520 .doi: 10.1038/s41594-021-00605-6

PMID: 34117479

Phospho-regulation, nucleotide binding and ion access control in potassium-chloride cotransporters.

Chi G, Ebenhoch R, Man H, Tang H, Tremblay LE, Reggiano G, Qiu X, Bohstedt T, Liko I, Almeida FG, Garneau AP, Wang D, McKinley G, Moreau CP, Bountra KD, Abrusci P, Mukhopadhyay SMM, Fernandez-Cid A, Slimani S, Lavoie JL, Burgess-Brown NA, Tehan B, DiMaio F, Jazayeri A, Isenring P, Robinson CV, Dürr KL

EMBO J. 2021-5-25 . e107294 .doi: 10.15252/embj.2020107294

PMID: 34031912

Structure and activation mechanism of the human liver-type glutaminase GLS2.

Ferreira IM, Edwin N Quesñay J, Bastos AC, Rodrigues CT, Vollmar M, Krojer T, Strain-Damerell C, Burgess-Brown NA, von Delft F, Yue WW, Dias SM, Ambrosio AL

Biochimie. 2021-3-18 . .doi: 10.1016/j.biochi.2021.03.009

PMID: 33746066

2020

Expression Screening of Human Integral Membrane Proteins Using BacMam.

Mahajan P, Ellis K, Mukhopadhyay S, Fernandez-Cid A, Chi G, Man H, Dürr KL, Burgess-Brown NA

Methods Mol Biol. 2020-10-31 . 2199:95-115 .doi: 10.1007/978-1-0716-0892-0_6

PMID: 33125646

Screening and Production of Recombinant Human Proteins: Ligation-Independent Cloning.

Strain-Damerell C, Mahajan P, Fernandez-Cid A, Gileadi O, Burgess-Brown NA

Methods Mol Biol. 2020-10-31 . 2199:23-43 .doi: 10.1007/978-1-0716-0892-0_3

PMID: 33125643

Screening and Production of Recombinant Human Proteins: Protein Production in Insect Cells.

Mahajan P, Strain-Damerell C, Mukhopadhyay S, Fernandez-Cid A, Gileadi O, Burgess-Brown NA

Methods Mol Biol. 2020-10-31 . 2199:67-94 .doi: 10.1007/978-1-0716-0892-0_5

PMID: 33125645

Screening and Production of Recombinant Human Proteins: Protein Production in E. coli.

Burgess-Brown NA, Mahajan P, Strain-Damerell C, Fernandez-Cid A, Gileadi O, Gräslund S

Methods Mol Biol. 2020-10-31 . 2199:45-66 .doi: 10.1007/978-1-0716-0892-0_4

PMID: 33125644

A lower X-gate in TASK channels traps inhibitors within the vestibule.

Rödström KEJ, Kiper AK, Zhang W, Rinné S, Pike ACW, Goldstein M, Conrad LJ, Delbeck M, Hahn MG, Meier H, Platzk M, Quigley A, Speedman D, Shrestha L, Mukhopadhyay SMM, Burgess-Brown NA, Tucker SJ, Müller T, Decher N, Carpenter EP

Nature. 2020-4-29 . .doi: 10.1038/s41586-020-2250-8

PMID: 32499642